Correlation Between Forte Biosciences and Cyteir Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Forte Biosciences and Cyteir Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Forte Biosciences and Cyteir Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Forte Biosciences and Cyteir Therapeutics, you can compare the effects of market volatilities on Forte Biosciences and Cyteir Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Forte Biosciences with a short position of Cyteir Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Forte Biosciences and Cyteir Therapeutics.

Diversification Opportunities for Forte Biosciences and Cyteir Therapeutics

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Forte and Cyteir is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Forte Biosciences and Cyteir Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyteir Therapeutics and Forte Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Forte Biosciences are associated (or correlated) with Cyteir Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyteir Therapeutics has no effect on the direction of Forte Biosciences i.e., Forte Biosciences and Cyteir Therapeutics go up and down completely randomly.

Pair Corralation between Forte Biosciences and Cyteir Therapeutics

If you would invest  709.00  in Forte Biosciences on September 17, 2024 and sell it today you would earn a total of  1,606  from holding Forte Biosciences or generate 226.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy1.54%
ValuesDaily Returns

Forte Biosciences  vs.  Cyteir Therapeutics

 Performance 
       Timeline  
Forte Biosciences 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Forte Biosciences are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Forte Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
Cyteir Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyteir Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Cyteir Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Forte Biosciences and Cyteir Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Forte Biosciences and Cyteir Therapeutics

The main advantage of trading using opposite Forte Biosciences and Cyteir Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Forte Biosciences position performs unexpectedly, Cyteir Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyteir Therapeutics will offset losses from the drop in Cyteir Therapeutics' long position.
The idea behind Forte Biosciences and Cyteir Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital